As of 2025-12-30, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.03 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.05 CAD, the upside of BetterLife Pharma Inc is -161.46%.
Based on its market price of 0.05 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 161.46%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.03 - -0.03 | -0.03 | -161.46% |
| DDM - Stable | (0.04) - (0.15) | (0.10) | -317.2% |
| DDM - Multi | (0.59) - (1.57) | (0.86) | -2007.6% |
| Market Cap (mil) | 6.83 |
| Beta | 1.55 |
| Outstanding shares (mil) | 151.84 |
| Enterprise Value (mil) | 7.45 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.99% |
| Cost of Debt | 5.00% |
| WACC | 9.24% |